Primary squamous cell cancer (SqCC) of the breast is a rather rare disease. These tumors are known to be
quite aggressive in nature and are usually found to be treatment-resistant. Currently, there is no standard treatment
guideline for the management of primary SqCC of the breast. In this case report, we present a case of primary SqCC of
the breast in 60-year old postmenopausal women presenting as pigmented lesion over the right breast (no lump). Initial
skin biopsy (core) done by dermatologist revealed squamous cell cancer in situ (Bowen’s disease); however surgical
resection of the lesion and subsequent histopathological examination revealed primary SqCC (no secondary sites were
found elsewhere in the body).
2. Picture 1: Clinical photograph of the lesion.
Picture 2: Squamous cell carcinoma in situ. (Bowen’s disease)
Full thickness dysplasia of epidermis marked by black arrow.
(H&E 10X)
the lesion. (Figure 3A). The lesion was resected with 1.5 cm
depth into the subcutaneous tissues (Figure 3B and 3C). The
incision was closed primarily. (Figure 4) The specimen was
sent for histopathological examination which revealed the lesion
to be of basaloid variant of invasive squamous cell carcinoma
(Figure 5A and 5B). The margins of the specimen were all free
of tumour. Immunohistochemistry (IHC) markers for P40 were
positive confirming SqCC (Figure 6). Postoperative recovery
was uneventful. The patient has been following up for three
months with no recurrence.
No chemotherapy or radiotherapy was offered to the patient.
Discussion
Literature review revealed that primary SqCC of the breast is
quite rare, and it usually follows an aggressive course. Com-
pared to primary SqCC of the breast, metastasis to breast tissue
from other primary sites of cancer like lungs, skin, stomach,
or skin, are quite common. [7] Postmenopausal women are
more commonly found to have primary SqCC of breast tissue
[7, 9]; however, there are several reports of the same occurring
in younger women [7, 8]. Reported cases of primary SqCC of
breast revealed the usual size of the lesion to be as large as 8 cm;
Picture 3a: Incision marked with a margin of 5 mm all around.
Picture 3b: Resected specimen.
Picture 3c: Adequate resection extending into the subcutaneous
tissues.
Ketan Vagholkar et al./ International Journal of Surgery and Medicine (2020) 6(4):32-35
3. Picture 4: After healing of the incision.
usually larger than breast adenocarcinoma [6].
There are usually no specific mammographic or ultrasound
features for primary SqCC of the breast. The biopsy is the only
confirmatory investigation. HP examination revealed the pres-
ence of sheets of malignant squamous cells within between in-
tercellular bridges and keratin deposits. In our case, the lesion
was positive for IHC marker P40, which was confirmatory for
SqCC. There was no axillary (neither ipsilateral nor contralateral)
lymph nodal involvement in our patient. Similar to our findings,
the literature review also revealed that 70% of the patients with
breast SqCC do not have axillary lymph node involvement [9].
Moreover, there are number of criteria for the diagnosis of
primary SqCC of the breast; these are the tumor should not arise
from the surface of the skin of the breast or that of the nipple, 90%
of the tumor cells are squamous in nature, thorough exclusion
of the tumor as being secondary in nature metastasizing from
other extramammary sites, and absence of neoplastic ductal or
mesenchymal elements [1-5].
In the present case, the patient satisfied all the above men-
tioned four criteria.
Due to the rarity of this tumor, the treatment strategy for
primary SqCC is not yet established. Currently, employed treat-
ment strategies are taken from treatment strategies for manage-
ment of invasive ductal and lobular breast cancers. In our case,
the patient was managed with total surgical resection of the
lesion; no adjuvant chemotherapy or radiotherapy was given as
it was a circumscribed lesion which was completely removed.
However, a literature search revealed that there are published
reports of primary SqCC where patients received multifaceted
therapy involving surgical resection of lesions, chemotherapy,
radiotherapy and also anti-estrogen drugs. But the efficacy of
this type of multidimensional treatment strategy is not yet estab-
lished, especially due to the rare occurrence of the tumor. Some
of the SqCC tumors of the breast are found to be radiosensitive,
and some are not [10].
Again chemotherapeutic drugs usually used for management
of invasive ductal carcinoma of the breast might not be effective
for SqCC of the breast. Aparicio I and his colleagues published
a study through compilation and analysis of data on patients
diagnosed with SqCC of the breast from 1979 to 2006 [6]. They
found 11 such cases out of a total of 5771 breast cancer cases.
Picture 5a: Squamous cell carcinoma: Dysplastic stratified squa-
mous epithelium invading the underlying dermis in the form of
lobules, nests and cords. Upper dermis shows pigment inconti-
nence. Deep dermis and subcutaneous tissues are unremarkable.
(H&E 40X)
Picture 5b: Individual tumour cells are basaloid with round
to polygonal shape, pleomorphic and hyperchromatic nuclei.
Tumour nests show peripheral palisading. (H&E 400X).
Ketan Vagholkar et al./ International Journal of Surgery and Medicine (2020) 6(4):32-35
4. Picture 6: Immunohistochemistry showing nuclear positivity in
tumour cells for P40 (100X).
They found the tumors were aggressive in nature and usually
were treatment refractory. Moreover, they noted that there was
no survival benefit for SqCC patients receiving neoadjuvant
or adjuvant chemotherapy compared to patients who did not
receive chemotherapy.
Also, the tumors being hormone receptor-negative, hormone
blockade might be quite ineffective.
Prognosis of primary SqCC of the breast is not clear. Some of
the published reports claim the outcome to be similar to those
of poorly differentiated breast cancer (low overall survival rate).
Aparicio, I and his colleagues found the mean disease-free sur-
vival interval to be 92 months [6]. In another case report on
primary SqCC of breast cancer, the patient was doing well after
surgical resection of the tumour alone at 36 months after surgery.
Similarly, another case reported by Carbone S and her colleagues
where 51 year old women diagnosed with primary SqCC tumor
of breast was managed with breast conserving surgery (lumpec-
tomy) and adjuvant chemotherapy and radiotherapy [11].
In the case presented the patient did not present with breast
lump rather only with pigmented lesion over right breast (that
is why she consulted dermatologist at first). Initial biopsy report
was that of Squamous cell carcinoma in situ (Bowen’s disease).
However, surgical removal of the lesion revealed the actual
nature of the tumor (primary SqCC of the breast).
Conclusion
Hence before coming to any conclusion regarding pigmented
lesions of the breast, surgical resection and subsequent biopsy of
the lesion is mandatory for confirmation of diagnosis and also
to avoid the wrong diagnosis.
Conflict of interest
There are no conflicts of interest to declare by any of the authors
of this study.
Acknowledgement
I would like to thank the Dean of D.Y.Patil University School of
Medicine for allowing me to publish the case report.
References
1. Gupta G., Malani A.K., Weigand R.T., Rangenini G. Pure pri-
mary squamous cell carcinoma of the breast: a rare presen-
tation and clinicopathologic comparison with usual ductal
carcinoma of the breast. Pathol Res Pract. 2006; 6:465–469.
2. Behranwala K.A., Nasiri N., Abdullah N., Trott P.A., Gui
G.P.H. Squamous cell carcinoma of the breast: clinico-
pathologic implications and outcome. Eur J Surg Oncol.
2003;29:386–389
3. Anne N, Sulger E, Pallapothu R. Primary squamous cell
carcinoma of the breast: a case report and review of the
literature. J Surg Case Rep. 2019 Jun 14; 2019(6):rjz182.
4. Weigel RJ, Ikeda DM, Nowels KW. Primary squamous cell
carcinoma of the breast. South Med J. 1996 May; 89(5):511-5.
5. Stevenson JT, Graham DJ, Khiyami A, Mansour EG. Squa-
mous cell carcinoma of the breast: a clinical approach. Ann
Surg Oncol. 1996 Jul; 3(4):367-74.
6. Aparicio I, Martínez A, Hernández G, Hardisson D, De
Santiago J. Squamous cell carcinoma of the breast. Eur J
Obstet Gynecol Reprod Biol. 2008 Apr; 137(2):222-6.
7. Gürsel B, Bayrak IK, Gokce SC, Yildiz L, Gürsel M, Yücel I.
Primary squamous cell carcinoma of the breast: A case re-
port and review of the literature. Turkish Journal of Cancer
2007; 37:114–6.
8. Aparicio I, Martínez A, Hernández G, Hardisson D, De
Santiago J. Squamous cell carcinoma of the breast. Eur J
Obstet Gynecol Reprod Biol. 2008 Apr; 137(2):222-6.
9. Stevenson JT, Graham DJ, Khiyami A, Mansour EG. Squa-
mous cell carcinoma of the breast: a clinical approach. Ann
Surg Oncol. 1996 Jul; 3(4):367-74.
10. Carbone S, Lobo Alvarez R, Lamacchia A, Almenar Gil A,
Martin Hernandez R, Lopez Guerra JL, Marsiglia H. Pri-
mary squamous cell carcinoma of the breast: A rare case
report. Rep Pract Oncol Radiother. 2012; 17(6):363-6.
11. Carbone S, Lobo Alvarez R, Lamacchia A, Almenar Gil A,
Martin Hernandez R, Lopez Guerra JL, Marsiglia H. Pri-
mary squamous cell carcinoma of the breast: A rare case
report. Rep Pract Oncol Radiother. 2012 Aug 9; 17(6):363-6.
Ketan Vagholkar et al./ International Journal of Surgery and Medicine (2020) 6(4):32-35